TNFSF10 and cancer: Cabazitaxel and TRAIL induced apoptosis in 62.3% ± 9.3% of cancer cells in a concentration of 0.25 μM and 66.1% ± 8.8% in a concentration of 0.5 μM in PC3 cells.